Skip to main content
. 2022 Sep 9;23(18):10466. doi: 10.3390/ijms231810466

Figure 4.

Figure 4

Figure 4

Interactions diagram of JAK1 kinase interactions with decernotinib (a), with KEV ligand (b), and with ruxolitinib (c); JAK2 kinases with decernotinib (d), with KEV ligand (e), and with ruxolitinib (f) (Supplementary materials, Figures S7–S12).